MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma (Q35096201)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma |
scientific article |
Statements
1 reference
MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma (English)
1 reference
Emily K Slotkin
1 reference
Parag P Patwardhan
1 reference
Shyamprasad D Vasudeva
1 reference
William D Tap
1 reference
Gary K Schwartz
1 reference
17 December 2014
1 reference
1 reference
14
1 reference
2
1 reference
395-406
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference